gadolinium dtpa has been researched along with diethylnitrosamine in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (diethylnitrosamine) | Trials (diethylnitrosamine) | Recent Studies (post-2010) (diethylnitrosamine) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 3,614 | 1 | 888 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuhama, K; Hirose, T; Ikehira, H; Kato, H; Miyahara, K; Nakayama, W; Sato, H; Sato, M; Sugihara, H; Tateno, Y; Yamada, K | 1 |
1 other study(ies) available for gadolinium dtpa and diethylnitrosamine
| Article | Year |
|---|---|
Contrast-enhanced MRI with gadodiamide injection in rat disease models.
Topics: Animals; Arterial Occlusive Diseases; Carcinogens; Cerebral Arterial Diseases; Cerebrovascular Disorders; Contrast Media; Diethylnitrosamine; Gadolinium; Gadolinium DTPA; Hydronephrosis; Injections, Intravenous; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Rats, Inbred SHR; Rats, Sprague-Dawley | 1996 |